Indications of Hypen SR 1.5 mg
Hypen SR 1.5 mg is indicated in the treatment of essential hypertension . It is effective in treating hypertension in patients with renal function impairment, although its diuretic effect is reduced. Hypen SR 1.5 mg is also indicated for the treatment of salt and fluid retention associated with congestive heart failure.
Theropeutic Class
Thiazide diuretics & related drugs
Pharmacology
Hypen SR 1.5 mg is a diuretic antihypertensive. It appears to cause vasodilation, probably by inhibiting the passage of calcium and other ions (sodium, potassium) across membranes. It has an extra-renal antihypertensive action resulting in a decrease in vascular hyperreactivity and a reduction in total peripheral and arteriolar resistance.
Dosage & Administration of Hypen SR 1.5 mg
One tablet daily preferably in the morning. In more sever case Hypen SR 1.5 mg can be combine with other categories of anti-hypertensive agent. The safety and effectiveness in pediatric patients have not been established
Dosage of Hypen SR 1.5 mg
One tablet daily preferably in the morning. In more sever case Hypen SR 1.5 mg can be combine with other categories of anti-hypertensive agent. The safety and effectiveness in pediatric patients have not been established
Interaction of Hypen SR 1.5 mg
Other antihypertensive: Hypen SR 1.5 mg may add to or potentiate the action of other antihypertensive drugs. Norepinephrine: Hypen SR 1.5 mg like thiazides, may decrease arterial responsiveness to norepinephrine. Lithium: In general, diuretics should not be given concomitantly with lithium because they reduce its renal clearance and add a high risk of lithium toxicity.
Contraindications
This drug must not be taken in the following conditions:
Hypersensitivity to sulfonamides
Severe renal failure
Hepatic encephalopathy or severe hepatic failure
Hypokalaemia
Side Effects of Hypen SR 1.5 mg
Side effects of Hypen SR 1.5 mg include headache, anorexia, gastric irritation,nausea, vomiting, constipation, diarrhoea etc.
Pregnancy & Lactation
There are no adequate and well-controlled studies in pregnant women and so Hypen SR 1.5 mg is not recommended. Mothers taking Hypen SR 1.5 mg should not breast feed.
Precautions & Warnings
Monitoring of potassium and uric acid serum levels is recommended, especially in subjects with a predisposition or sensitivity to hypokalemia and in patients with gout. Although no allergic manifestations have been reported during clinical trials, patients with a history of allergy to sulfonamide derivatives should be closely monitored.
Overdose Effects of Hypen SR 1.5 mg
Symptoms: These could include: allergies, skin rashes, epigastric pain, nausea, photosensitivity, dizziness, weakness and paraesthesia.Treatment: Treatment is supportive and symptomatic, directed at correcting the electrolyte abnormalities.
Storage Conditions
Store in a cool and dry place. Protect from light and moisture.
Drug Classes
Thiazide diuretics & related drugs
Mode Of Action
Hypen SR 1.5 mg is a diuretic antihypertensive. It appears to cause vasodilation, probably by inhibiting the passage of calcium and other ions (sodium, potassium) across membranes. It has an extra-renal antihypertensive action resulting in a decrease in vascular hyperreactivity and a reduction in total peripheral and arteriolar resistance.
Pregnancy
There are no adequate and well-controlled studies in pregnant women and so Hypen SR 1.5 mg is not recommended. Mothers taking Hypen SR 1.5 mg should not breast feed.